Findings indicate that robotic-assisted hepatectomy in a high-volume center leads to shorter hospital stays, fewer complications, and lower severe morbidity rates compared to traditional methods. Analyzing 111 patients from Lille University Hospital revealed costs dropped from €12,169 in 2018 to €8,513 in 2021, cumulatively saving €259,576 for the 71 patients in the latter cohort. These […]

The global health burden of gallbladder and biliary diseases persists, with the age-standardized incidence rate decreasing by 12.84% from 1990 to 2021. However, the absolute number of cases increased by 60.11%, primarily due to population aging and growth. Health inequalities persist, particularly in high-burden regions like Honduras, with disparities in healthcare workforce density relative to […]

A randomized controlled trial found that splenic artery ligation significantly decreases the incidence of grades b and c posthepatectomy liver failure in patients with elevated portal venous pressure. Among 36 participants with high pressure, those receiving the intervention had a failure rate of 16.67% compared to 66.67% in the control group (p = .006). The […]

The PANAMA score effectively stratifies pancreatic cancer patients post-resection into low-, intermediate-, and high-risk categories, correlating with median overall survival rates of 48.5, 27.6, and 22.3 months, respectively. Adjuvant therapy demonstrated no survival benefit in low-risk patients, while significant improvements were seen in both intermediate (HR: 0.58) and high-risk groups (HR: 0.47). This validation underscores […]

The integration of transarterial chemoembolization (TACE) with tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) notably improves the objective response rate (RR = 1.81) and disease control rate (RR = 1.32) compared to TKIs and ICIs alone. Additionally, overall survival and progression-free survival are significantly prolonged, with hazard ratios of 0.55 and 0.73, respectively. […]

In a cohort study of 251 patients with pancreatic ductal adenocarcinoma, neoadjuvant therapy followed by surgical resection significantly improved overall survival (39.87 months vs. 18.86 months) and recurrence-free survival (25.67 months vs. 12.83 months) compared to upfront surgery. Elevated carcinoembryonic antigen (CEA) levels were linked to worse survival outcomes, underscoring their prognostic significance. The results […]

Carboxypeptidase z (cpz) demonstrates significant diagnostic potential for differentiating hepatocellular carcinoma (HCC) from intrahepatic cholangiocarcinoma (ICC). The study found cpz expressed in 90.8% of HCC cases, compared to 27.7% in ICC. Diagnostic accuracy was enhanced when cpz was combined with arginase-1 and hepatocyte paraffin antigen-1. Specifically, using all three markers yielded a sensitivity of 70.8% […]

A novel risk-stratification model for statistical cure after hepatectomy in hepatitis B virus-associated hepatocellular carcinoma (HBV-HCC) reveals an overall cure probability of 21.2%. The study identified eight independent risk factors, including high viral load and macrovascular invasion, that significantly influence outcomes. Low-risk patients achieved a 30.3% initial cure rate, with a remarkable 95% probability of […]

An analysis of the National Health Interview Survey highlights significant financial toxicity among U.S. patients with hepatopancreatobiliary (HPB) cancers. Of 5.6 million adults, 10.1% delayed medical care due to cost, while 8.4% could not afford necessary treatment. Uninsured patients faced markedly higher odds of financial challenges, and non-white patients were also more likely to delay […]